Prognosis value of a genetic score based on germline genetic variants in a prospective cohort of early triple-negative breast cancer patients.

Authors

null

Elsa Curtit

University Hospital - Medical Oncology Department, Besançon, France

Julie Henriques , Sophie Paget-Bailly , Sylvain Ladoire , Ariane Darut-Jouve , Marc Debled , Gilles Romieu , Claire Garnier-Tixidre , Jean-Philippe Jacquin , Patrick Soulie , Christelle Jouannaud , Maria Rios , Thierry Petit , Thomas Denis Bachelot , Céline Faure-Mercier , Laetitia Gambotti , Hélène Blanché , Jean-Francois Deleuze , David Cox , Xavier Pivot , Elsa Curtit

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention, Hereditary Genetics, and Epidemiology

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Genetics

Clinical Trial Registration Number

RECF1098

Citation

J Clin Oncol 37, 2019 (suppl; abstr 1529)

DOI

10.1200/JCO.2019.37.15_suppl.1529

Abstract #

1529

Poster Bd #

23

Abstract Disclosures

Similar Posters